GENZYME
Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease. Genzyme operates in four business segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases... , including a family of diseases known as lysosomal storage disorders (LSDs). Cardiometabolic and Renal segment develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure and endocrine and cardiovascular diseases. Biosurgery develops, manufactures and distributes biotherapeutics and biomaterial-based products. Hematologic Oncology develops, manufactures and distributes products for the treatment of cancer.
GENZYME
Industry:
Biopharma Biotechnology Genetics
Founded:
1981-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.genzyme.com
Total Employee:
10001+
Status:
Active
Contact:
6177686618
Technology used in webpage:
Domain Not Resolving Google Maps AJAX Libraries API JQuery CDN ASP.NET Ajax Facebook Like Button Apple Whitelist ShareThis The Trade Desk ComScore
Similar Organizations
LC Sciences
LC Sciences is a biotech company that provides products and services to genomics and proteomics researchers.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-05-29 | Bioenvision | Bioenvision acquired by Genzyme | 345 M USD |
| 2006-10-17 | AnorMED | AnorMED acquired by Genzyme | 580 M USD |
| 2005-07-01 | BoneCare International | BoneCare International acquired by Genzyme | 719 M USD |
| 2005-02-09 | Verigen | Verigen acquired by Genzyme | N/A |
| 2004-12-20 | ILEX Oncology,Inc. | ILEX Oncology,Inc. acquired by Genzyme | 1000 M USD |
| 2003-09-10 | SangStat | SangStat acquired by Genzyme | N/A |
| 2000-12-18 | Biomatrix | Biomatrix acquired by Genzyme | 738 M USD |
| 1997-06-16 | Pharmagenics | Pharmagenics acquired by Genzyme | 28 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-02-11 | Voyager Therapeutics | Genzyme investment in Corporate Round - Voyager Therapeutics | 30 M USD |
| 2014-01-13 | Alnylam Pharmaceuticals | Genzyme investment in Post-IPO Equity - Alnylam Pharmaceuticals | 700 M USD |
| 2008-09-23 | Humanigen | Genzyme investment in Series D - Humanigen | 20 M USD |
| 2006-06-07 | Peptimmune | Genzyme investment in Series C - Peptimmune | 12 M USD |
Newest Events participated
Participated in 3rd World Congress on Thyroid Cancer
on 2017-07-27 as exhibitor
Official Site Inspections
http://www.genzyme.com
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
